Peter Barth

8.5k total citations · 1 hit paper
149 papers, 6.2k citations indexed

About

Peter Barth is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Peter Barth has authored 149 papers receiving a total of 6.2k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Pulmonary and Respiratory Medicine, 45 papers in Surgery and 42 papers in Oncology. Recurrent topics in Peter Barth's work include Neonatal Respiratory Health Research (16 papers), Pancreatic and Hepatic Oncology Research (10 papers) and Neuroendocrine Tumor Research Advances (8 papers). Peter Barth is often cited by papers focused on Neonatal Respiratory Health Research (16 papers), Pancreatic and Hepatic Oncology Research (10 papers) and Neuroendocrine Tumor Research Advances (8 papers). Peter Barth collaborates with scholars based in Germany, United States and United Kingdom. Peter Barth's co-authors include Annette Ramaswamy, Birte Steiniger, Roland Moll, Rudolf Arnold, Klaus‐Jochen Klose, Hans‐Helge Müller, Thomas M. Gress, Carmen Schade‐Brittinger, Anja Rinke and M. Wied and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Peter Barth

147 papers receiving 6.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group

2009 1.8k citations Anja Rinke, Hans‐Helge Müller et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peter Barth Germany	40	2.9k	2.4k	1.6k	1.4k	1.3k	149	6.2k
Fausto Sessa Italy	46	4.2k 1.5×	2.5k 1.1×	1.1k 0.7×	1.6k 1.1×	2.2k 1.7×	204	7.7k
Bita Esmaeli United States	46	3.7k 1.3×	1.9k 0.8×	684 0.4×	1.0k 0.7×	1.8k 1.5×	271	8.1k
Kiyoshi Mukai Japan	45	1.7k 0.6×	912 0.4×	1.1k 0.7×	1.4k 1.0×	1.3k 1.0×	166	5.9k
Jiří Bártek Denmark	41	2.0k 0.7×	897 0.4×	1.4k 0.9×	2.2k 1.6×	957 0.8×	168	6.4k
Swee T. Tan New Zealand	39	1.5k 0.5×	719 0.3×	964 0.6×	1.6k 1.1×	2.2k 1.8×	191	5.3k
Nobuaki Funata Japan	37	1.0k 0.4×	1.5k 0.6×	645 0.4×	1.5k 1.1×	2.3k 1.8×	139	5.6k
Paul S. Thorner Canada	49	1.9k 0.7×	825 0.3×	1.8k 1.1×	3.5k 2.5×	1.6k 1.3×	321	9.1k
Ziv Gil Israel	44	2.0k 0.7×	1.1k 0.4×	369 0.2×	1.4k 1.0×	3.2k 2.5×	169	6.9k
Pierre Bordigoni France	50	1.9k 0.7×	1.3k 0.5×	578 0.4×	1.3k 0.9×	454 0.4×	203	8.0k
Herwart F. Otto Germany	38	905 0.3×	973 0.4×	658 0.4×	1.1k 0.8×	1.1k 0.9×	169	4.5k

Countries citing papers authored by Peter Barth

Since Specialization

Citations

This map shows the geographic impact of Peter Barth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Barth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Barth more than expected).

Fields of papers citing papers by Peter Barth

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Barth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Barth. The network helps show where Peter Barth may publish in the future.

Co-authorship network of co-authors of Peter Barth

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Barth. A scholar is included among the top collaborators of Peter Barth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Barth. Peter Barth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Roy, Dhruvajyoti, Emile Rijcken, Peter Barth, et al.. (2024). Robotic-assisted esophagectomy with total mesoesophageal excision enhances R0-resection in patients with esophageal cancer: A single-center experience. Surgery. 176(3). 721–729. 5 indexed citations

Schughart, Klaus, Rainer Wiewrodt, Stefan Fischer, et al.. (2024). Molecular characterisation of influenza B virus from the 2017/18 season in primary models of the human lung reveals improved adaptation to the lower respiratory tract. Emerging Microbes & Infections. 13(1). 2402868–2402868. 1 indexed citations

Schloer, Sebastian, Rainer Wiewrodt, Karsten Wiebe, et al.. (2022). 3D Ex vivo tissue platforms to investigate the early phases of influenza a virus- and SARS-CoV-2-induced respiratory diseases. Emerging Microbes & Infections. 11(1). 2160–2175. 6 indexed citations

Beuker, Carolin, Christian Thomas, Jan‐Kolja Strecker, et al.. (2021). Characterization of Extracranial Giant Cell Arteritis with Intracranial Involvement and its Rapidly Progressive Subtype. Annals of Neurology. 90(1). 118–129. 14 indexed citations

Barth, Peter, Joke Tio, Hans‐Christian Kolberg, et al.. (2019). Correlation Between Sfrp1 Expression and Clinicopathological Parameters in Patients With Triple-Negative Breast Cancer. Future Oncology. 15(16). 1921–1938. 13 indexed citations

Bernemann, Christof, Christian Rückert, Georg Hempel, et al.. (2014). Influence of secreted frizzled receptor protein 1 (SFRP1) on neoadjuvant chemotherapy in triple negative breast cancer does not rely on WNT signaling. Molecular Cancer. 13(1). 174–174. 48 indexed citations

Rinke, Anja, Hans‐Helge Müller, Carmen Schade‐Brittinger, et al.. (2009). Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group. Journal of Clinical Oncology. 27(28). 4656–4663. 1773 indexed citations breakdown →

Neeße, Albrecht, Patrick Michl, Peter Barth, et al.. (2009). Multifocal Early Gastric Cancer in a Patient with Autoimmune Atrophic Gastritis and Iron Deficiency Anaemia. Zeitschrift für Gastroenterologie. 47(2). 223–227. 4 indexed citations

Fernández, Emilio Domínguez, Thomas M. Behr, Peter Barth, et al.. (2008). Does Fine-Needle Aspiration Cytology Optimize the Surgical Management of Thyroid Disorders in Endemic Goiter Region?. Endocrine Pathology. 19(1). 34–39. 3 indexed citations

10.

Jäkel, Jörg, Annette Ramaswamy, Ulrich Köhler, & Peter Barth. (2006). Massive pulmonary tumor microembolism from a hepatocellular carcinoma. Pathology - Research and Practice. 202(5). 395–399. 14 indexed citations

11.

Olbert, P., Alexander H. Dalpke, Klaus Heeg, et al.. (2004). 823 Antineoplastic effect of immunostimulative DNA (CPG-ODN) in a murine C57-BL6/MB-49 transitional cell carcinoma model. European Urology Supplements. 3(2). 208–208. 2 indexed citations

12.

Zielke, A., Martin Middeke, Sebastian Hoffmann, et al.. (2002). VEGF-mediated angiogenesis of human pheochromocytomas is associated to malignancy and inhibited by anti-VEGF antibodies in experimental tumors. Surgery. 132(6). 1056–1063. 44 indexed citations

13.

Barth, Peter, et al.. (2001). CD34+ fibrocytes in invasive ductal carcinoma, ductal carcinoma in situ, and benign breast lesions. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 440(3). 298–303. 111 indexed citations

14.

Steiniger, Birte, Peter Barth, & A. Hellinger. (2001). The Perifollicular and Marginal Zones of the Human Splenic White Pulp. American Journal Of Pathology. 159(2). 501–512. 102 indexed citations

15.

Simon, Babette, Peter Barth, Nicole Prasnikar, et al.. (1998). Frequent abnormalities of the putative tumor suppressor gene FHIT at 3p14.2 in pancreatic carcinoma cell lines.. PubMed. 58(8). 1583–7. 46 indexed citations

16.

Bartsch, Detlef K., Bastian Daniel, Peter Barth, et al.. (1998). K-ras Oncogene Mutations Indicate Malignancy in Cystic Tumors of the Pancreas. Annals of Surgery. 228(1). 79–86. 74 indexed citations

17.

Barth, Peter, et al.. (1997). Histological determinants of the vascular surface in prostatic carcinoma. Urological Research. 25(5). 303–308. 4 indexed citations

18.

Barth, Peter, Markus Wolf, & A. Ramaswamy. (1994). Distribution and Number of Clara Cells in the Normal and Disturbed Development of the Human Fetal Lung. Pediatric Pathology. 14(4). 637–651. 21 indexed citations

19.

Kaiser, Ulrich, et al.. (1994). Primary Osteosarcoma of the Breast—Case Report and Review of the Literature. Acta Oncologica. 33(1). 74–76. 16 indexed citations

20.

Bittinger, A., et al.. (1994). Nuclear morphometry of soft tissue tumors of fibrous origin.. PubMed. 140(4-5). 351–6. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact